A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Recruiting

Phase 1

Phase 2

PF-08634404A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Sponsor:

Pfizer

Code:

NCT07227415

Conditions

Carcinoma, Renal Cell

Advanced Renal Cell Carcinoma

Renal Cancer

Renal Neoplasm

Clear Cell Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08634404

Combination 1

Combination 2

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-08. This information was provided to ClinicalTrials.gov by Pfizer on 2026-03-02.